Alumis Inc. Common Stock
$7.82
-$0.12 (-1.51%)
$7.75Day Range$8.11
Key Statistics
Market Cap
$1.01B
Shares Outstanding
129.4M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Jun 28, 2024
Round Lot
100
Locale
US
Trading Data
Day Open
$8.03
Day High
$8.11
Day Low
$7.75
Volume
3.52M
VWAP
$7.84
Prev Close
$7.94
Transactions
--
Acc. Volume
--
About Alumis Inc. Common Stock
Alumis Inc is a clinical-stage biopharmaceutical company with an initial focus on developing its two Tyrosine Kinase 2 ("TYK2") inhibitors: envudeucitinib ("envu"), an allosteric TYK2 inhibitor for the treatment of PsO and SLE; and A-005, a central nervous system ("CNS") penetrant allosteric TYK2 inhibitor, to offer the therapeutic benefit of TYK2 inhibition within the CNS for a broad range of neuroinflammatory and neurodegenerative diseases.
PHARMACEUTICAL PREPARATIONSSIC 2834239 employees280 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, 94080650-231-6625IPO Jun 28, 2024US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001847367
- Composite FIGI
- BBG01J7X4PN2
- Share Class FIGI
- BBG01J7X4PP0
- Ticker Root
- ALMS
- SIC Code
- 2834
About Alumis Inc. Common Stock (ALMS) Stock
Alumis Inc. Common Stock (ALMS) closed the 2026-09-17 session at $7.82, down 1.51% versus the previous close (-0.12). The stock opened at $8.03 and traded between $7.75 and $8.11 during that session. Session trading volume was 3.5M shares. The volume-weighted average price (VWAP) is $7.84.
Alumis Inc is a clinical-stage biopharmaceutical company with an initial focus on developing its two Tyrosine Kinase 2 ("TYK2") inhibitors: envudeucitinib ("envu"), an allosteric TYK2 inhibitor for the treatment of PsO and SLE; and A-005, a central nervous system ("CNS") penetrant allosteric TYK2 inhibitor, to offer the therapeutic benefit of TYK2 inhibition within the CNS for a broad range of neuroinflammatory and neurodegenerative diseases.
Alumis Inc. Common Stock has a market capitalization of $1.01 billion. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. ALMS is listed on the XNAS exchange. The company employs approximately 239 people. Alumis Inc. Common Stock is headquartered in SOUTH SAN FRANCISCO, CA. The recorded listing date is 2024-06-28.
On this page you can find market ALMS stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.